BRD2 and metabolic disease: Furthermore, another study showed that FSH acts on the pituitary corticotropes to inhibit corticosterone production and ultimately prevent hepatic steatosis, and that FSH administration is sufficient to improve metabolic disorders including hepatic steatosis in female mice (55).